{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:09:45Z","timestamp":1793315385519,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010031","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000}}],"reference-count":138,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010031.pub2","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T12:21:50Z","timestamp":1500034910000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Oral antifungal medication for toenail onychomycosis"],"prefix":"10.1002","volume":"2017","author":[{"given":"Sanne","family":"Kreijkamp-Kaspers","sequence":"first","affiliation":[{"name":"The University of Queensland; Primary Care Clinical Unit, Faculty of Medicine; Level 8, Health Sciences Building 16\/910 Royal Brisbane & Women's Hospital Complex Brisbane Herston, Queensland Australia 4029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Hawke","sequence":"additional","affiliation":[{"name":"The University of Queensland; Primary Care Clinical Unit, Faculty of Medicine; Level 8, Health Sciences Building 16\/910 Royal Brisbane & Women's Hospital Complex Brisbane Herston, Queensland Australia 4029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Guo","sequence":"additional","affiliation":[{"name":"The University of Queensland; Primary Care Clinical Unit, Faculty of Medicine; Level 8, Health Sciences Building 16\/910 Royal Brisbane & Women's Hospital Complex Brisbane Herston, Queensland Australia 4029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kerin","sequence":"additional","affiliation":[{"name":"The University of Queensland; Primary Care Clinical Unit, Faculty of Medicine; Level 8, Health Sciences Building 16\/910 Royal Brisbane & Women's Hospital Complex Brisbane Herston, Queensland Australia 4029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally EM","family":"Bell-Syer","sequence":"additional","affiliation":[{"name":"Cochrane; Cochrane Editorial Unit; St Albans House 57-59 Haymarket London UK SW1Y 4QX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parker","family":"Magin","sequence":"additional","affiliation":[{"name":"The University of Newcastle; Discipline of General Practice, School of Medicine and Public Health; Newbolds Buiding, University of Newcastle, University Drive Newcastle Australia 2308"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie V","family":"Bell-Syer","sequence":"additional","affiliation":[{"name":"Severn Deanery; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke L","family":"van Driel","sequence":"additional","affiliation":[{"name":"The University of Queensland; Primary Care Clinical Unit, Faculty of Medicine; Level 8, Health Sciences Building 16\/910 Royal Brisbane & Women's Hospital Complex Brisbane Herston, Queensland Australia 4029"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"Suppl 2","key":"10.1002\/14651858.CD010031.pub2-BIB0001|cit1","first-page":"289","article-title":"Double blind comparison between terbinafine & griseofulvin in the treatment of fingernail and toe nail onychomycosis","volume":"38","author":"Al Rubaie","year":"1997","journal-title":"Australasian Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09546630252775171","article-title":"An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis","volume":"13","author":"Arca","year":"2002","journal-title":"Journal of Dermatological Treatment"},{"issue":"8","key":"10.1002\/14651858.CD010031.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-4362.1991.tb02648.x","article-title":"Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent","volume":"30","author":"Arenas","year":"1991","journal-title":"International Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1995.tb03600.x","article-title":"Open randomized comparison of itraconazole versus terbinafine in onychomycosis","volume":"34","author":"Arenas","year":"1995","journal-title":"International Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010031.pub2-BIB0006|cit5","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/0926-9959(95)96060-L","article-title":"A multicentre double-blind parallel group study comparing the efficacy, safety and tolerability of terbinafine (250 mg\/day) with griseofulvin (1g\/day) in the treatment of dermatophytic onychomycosis","volume":"5","author":"Baran","year":"1995","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639709160278","article-title":"Comparative multicentre double-blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis","volume":"8","author":"Baran","year":"1997","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-4362.1999.00713.x","article-title":"Terbinafine vs. placebo for onychomycosis in black patients","volume":"38","author":"Billstein","year":"1999","journal-title":"International Journal of Dermatology"},{"issue":"5 Pt 3","key":"10.1002\/14651858.CD010031.pub2-BIB0011|cit8","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0190-9622(98)70485-2","article-title":"Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails","volume":"38","author":"Brautigam","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 46","key":"10.1002\/14651858.CD010031.pub2-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.1996.tb15654.x","article-title":"German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection","volume":"134","author":"Brautigam","year":"1996","journal-title":"British Journal of Dermatology"},{"issue":"7010","key":"10.1002\/14651858.CD010031.pub2-BIB0009|cit10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.311.7010.919","article-title":"Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group","volume":"311","author":"Brautigam","year":"1995","journal-title":"BMJ"},{"issue":"7165","key":"10.1002\/14651858.CD010031.pub2-BIB0010|cit11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bmj.317.7165.1084","article-title":"Successful treatment of toenail mycosis with terbinafine and itraconazole gives long term benefits","volume":"317","author":"Brautigam","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0012|cit12","first-page":"24","article-title":"Ketoconazole and griseofulvin in the treatment of toenail dermatophyte onychomycosis","volume":"41","author":"Cullen","year":"1987","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"5 Pt 3","key":"10.1002\/14651858.CD010031.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0190-9622(98)70486-4","article-title":"Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg\/day versus itraconazole 200 mg\/day","volume":"38","author":"Backer","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 56","key":"10.1002\/14651858.CD010031.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.1999.00009.x","article-title":"Long-term outcomes in the treatment of toenail onychomycosis","volume":"141","author":"Cuyper","year":"1999","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/000155599750011020","article-title":"Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis","volume":"79","author":"Degreef","year":"1999","journal-title":"Acta Dermato-Venereologica"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010031.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0190-9622(97)70111-7","article-title":"Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial","volume":"37","author":"Drake","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0017|cit17","first-page":"217","article-title":"Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis","volume":"59","author":"Elewski","year":"1997","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(96)90519-8","article-title":"A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail","volume":"35","author":"Odom","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1067\/mjd.2002.119674","article-title":"Reactivity to trichophytin antigen in patients with onychomycosis: effect of terbinafine","volume":"46","author":"Elewski","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2133.2011.10660.x","article-title":"A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis","volume":"166","author":"Elewski","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD010031.pub2-BIB0021|cit21","first-page":"AB76","article-title":"A randomized, placebo- and active-controlled, parallel-group, multicenter,investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis","volume":"62","author":"Elewski","year":"2010","journal-title":"Journal of American Academy of Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010031.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0190-9622(95)91454-4","article-title":"Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis","volume":"32","author":"Faergemann","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 39","key":"10.1002\/14651858.CD010031.pub2-BIB0024|cit23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1992.tb00007.x","article-title":"Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial","volume":"126","author":"Goodfield","year":"1992","journal-title":"British Journal of Dermatology"},{"issue":"6835","key":"10.1002\/14651858.CD010031.pub2-BIB0023|cit24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.304.6835.1151","article-title":"Short term treatment of dermatophyte onychomycosis with terbinafine","volume":"304","author":"Goodfield","year":"1992","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09546630050517658","article-title":"Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study","volume":"11","author":"Gupta","year":"2000","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mjd.2001.110874","article-title":"Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly","volume":"44","author":"Gupta","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000051643","article-title":"Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes","volume":"202","author":"Gupta","year":"2001","journal-title":"Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mjd.2001.110644","article-title":"Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis","volume":"44","author":"Gupta","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1468-3083.2005.01212.x","article-title":"A phase I\/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis","volume":"19","author":"Gupta","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD010031.pub2-BIB0030|cit30","first-page":"AB151","article-title":"Pulse itraconazole versus continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus","volume":"54","author":"Gupta","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD010031.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1468-3083.2006.01698.x","article-title":"Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus","volume":"20","author":"Gupta","year":"2006","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2310\/7750.2013.12088","article-title":"Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole","volume":"17","author":"Gupta","year":"2013","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1468-3083.2008.03036.x","article-title":"The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis","volume":"23","author":"Gupta","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2133.2000.03247.x","article-title":"A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis","volume":"142","author":"Havu","year":"2000","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00019053-200220050-00003","article-title":"Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis","volume":"20","author":"Salo","year":"2002","journal-title":"PharmacoEconomics"},{"issue":"6","key":"10.1002\/14651858.CD010031.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.1985.tb02338.x","article-title":"A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis","volume":"112","author":"Hay","year":"1985","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD010031.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1995.01690200057011","article-title":"Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group","volume":"131","author":"Hofmann","year":"1995","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1468-3083.1997.tb00505.x","article-title":"Itraconazole versus terbinafine (Lamisil): which is better for the treatment of onychomycosis?","volume":"9","author":"Honeyman","year":"1997","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"8","key":"10.1002\/14651858.CD010031.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-4362.1996.tb03667.x","article-title":"Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail","volume":"35","author":"Jones","year":"1996","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0040|cit40","first-page":"12","article-title":"Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis","volume":"Spec No","author":"Kejda","year":"1999","journal-title":"Postgraduate Medicine"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD010031.pub2-BIB0041|cit41","first-page":"AB87","article-title":"A novel itraconazole tablet for the treatment of onychomycosis","volume":"62","author":"Kempers","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD010031.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AAC.37.10.2064","article-title":"Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole","volume":"37","author":"Korting","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"S1","key":"10.1002\/14651858.CD010031.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1468-3083.16.s1.1.x","article-title":"Terbinafine and itraconazol in the treatment of onychomycosis: results of 3 years observation","volume":"16","author":"Kouznetsov","year":"2002","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0044|cit44","first-page":"19","article-title":"Terbinafine vs griseofulvin in the treatment of dermatophyte onychomycosis","volume":"129","author":"Placa","year":"1994","journal-title":"Giornale Italiano di Dermatologia e Venereologia"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-4362.2001.01204.x","article-title":"Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis","volume":"40","author":"Lebwohl","year":"2001","journal-title":"International Journal of Dermatology"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD010031.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0190-9622(98)70492-X","article-title":"Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail","volume":"38","author":"Ling","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD010031.pub2-BIB0047|cit47","first-page":"758","article-title":"Randomised, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis","volume":"12","author":"Maddin","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0048|cit48","first-page":"IC1753","article-title":"A comparative study of efficacy of oral itraconazole and terbinafine pulse therapy in the treatment of onychomycosis","volume":"129","author":"Mishra","year":"2002","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/29.2.195","article-title":"Efficacy and safety of itraconazole in the long-term treatment of onychomycosis","volume":"29","author":"Piepponen","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/09546634.2015.1119781","article-title":"Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients","volume":"27","author":"Ranawaka","year":"2016","journal-title":"The Journal of dermatological treatment"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010031.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1111\/j.1468-3083.1998.tb00994.x","article-title":"US experience with fluconazole in nail infections","volume":"11","author":"Elewski","year":"1998","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD010031.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0190-9622(98)70493-1","article-title":"Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail","volume":"38","author":"Rich","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD010031.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7190","key":"10.1002\/14651858.CD010031.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group","volume":"318","author":"Evans","year":"1999","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2133.2002.04639.x","article-title":"Long-term results in patients with onychomycosis treated with terbinafine or itraconazole","volume":"146","author":"Heikkila","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"Suppl 56","key":"10.1002\/14651858.CD010031.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2133.1999.00008.x","article-title":"L.I.O.N. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis","volume":"141","author":"Sigurgeirsson","year":"1999","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD010031.pub2-BIB0058|cit58","first-page":"492","article-title":"Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis","volume":"48","author":"Warrick","year":"1999","journal-title":"Journal of Family Practice"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaad.2013.03.021","article-title":"A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis","volume":"69","author":"Sigurgeirsson","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2340\/0001555565143149","article-title":"Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis","volume":"65","author":"Svejgaard","year":"1985","journal-title":"Acta Dermato-venereologica"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2340\/0001555577238","article-title":"Long-term follow-up of toe-nail onychomycosis treated with terbinafine","volume":"77","author":"Brandrup","year":"1997","journal-title":"Acta Dermato-venereologica"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/0001555555776669","article-title":"Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up","volume":"77","author":"Svejgaard","year":"1997","journal-title":"Acta Dermato-venereologica"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000017990","article-title":"Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up","volume":"197","author":"Tosti","year":"1998","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0190-9622(96)80057-0","article-title":"Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy","volume":"34","author":"Tosti","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555570137140","article-title":"Itraconazole in onychomycosis. Open and double-blind studies","volume":"70","author":"Walsoe","year":"1990","journal-title":"Acta Dermato-venereologica"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1365-2133.1997.d01-1222.x","article-title":"Non-dermatophytes in onychomycosis of the toenails","volume":"136","author":"Ellis","year":"1997","journal-title":"British Journal of Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010031.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0190-9622(95)91815-9","article-title":"Terbinafine in onychomycosis of the toenail: a novel treatment protocol","volume":"33","author":"Watson","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0068|cit68","first-page":"139","article-title":"The long term efficacy and relapse rate of itraconazole pulse therapy versus terbinafine continuous therapy for toenail onychomycosis - a 96-week follow-up study","volume":"12","author":"Won","year":"2007","journal-title":"Korean Journal of Medical Mycology"},{"issue":"7","key":"10.1002\/14651858.CD010031.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7547\/87507315-89-7-339","article-title":"The safety of itraconazole in the diabetic population","volume":"89","author":"Albreski","year":"1999","journal-title":"Journal of the American Podiatric Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1346-8138.1996.tb04009.x","article-title":"Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach","volume":"23","author":"Alpsoy","year":"1996","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09546630600621953","article-title":"Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up","volume":"17","author":"Avner","year":"2006","journal-title":"Journal of Dermatological Treatment"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD010031.pub2-BIB0072|cit72","first-page":"AB133","article-title":"Onychomycosis recurrence: Long term follow-up of 2 oral terbinafine regimens and the effect of topical bifonazole solution","volume":"54","author":"Avner","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1-2","key":"10.1002\/14651858.CD010031.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1439-0507.1999.00404.x","article-title":"A comparison among four regimens of itraconazole treatment in onychomycosis","volume":"42","author":"Chen","year":"1999","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"De Cuyper C Long-term evaluation of terbinafine 250 and 500 mg daily in a 16-week oral treatment for toenail onychomycosis British Journal of dermatology 1996 156 7","DOI":"10.1046\/j.1365-2133.1996.d01-966.x"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.1996.03890250044008","article-title":"Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole","volume":"132","author":"Doncker","year":"1996","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2340\/0001555576219221","article-title":"Levels of fluconazole in normal and diseased nails during and after treatment of onychomycosis in toe-nails with fluconazole 150mg once weekly","volume":"76","author":"Faergemann","year":"1996","journal-title":"Acta Dermato-venereologica"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/09546639409080565","article-title":"Descriptive correlations between various doses of oral terbinafine and concentrations in nail","volume":"5","author":"Finlay","year":"1994","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0078|cit78","first-page":"251","article-title":"Tinea pedis. A multicenter trial to evaluate the efficacy and tolerance of a weekly dose of fluconazole","volume":"40","author":"Gomez","year":"1996","journal-title":"Dermatologia Revista Mexicana"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010031.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/09546639009089036","article-title":"Clinical results with terbinafine in onychomycosis","volume":"1","author":"Goodfield","year":"1990","journal-title":"Journal of Dermatological Treatment"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0080|cit80","first-page":"230","article-title":"A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis","volume":"136","author":"Havu","year":"1997","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2133.1999.02614.x","article-title":"Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison","volume":"140","author":"Havu","year":"1999","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2230.1987.tb01888.x","article-title":"A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis","volume":"12","author":"Hay","year":"1987","journal-title":"Clinical and Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0083|cit83","first-page":"817","article-title":"The treatment of extensive onychomycosis in aged patients","volume":"47","author":"Maleszka","year":"2001","journal-title":"Wiadomosci Parazytologiczne"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7547\/87507315-91-3-127","article-title":"Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations","volume":"91","author":"Pollak","year":"2001","journal-title":"Journal of the American Podiatric Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/000155500750012351","article-title":"Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis","volume":"80","author":"Safer","year":"2000","journal-title":"Acta Dermato-venereologica"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2230.1995.tb01353.x","article-title":"Nail incorporation kinetics of terbinafine in onychomycosis patients","volume":"20","author":"Schatz","year":"1995","journal-title":"Clinical and Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/09546639909056039","article-title":"Open randomized comparison of different itraconazole regimens for the treatment of onychomycosis","volume":"10","author":"Shemer","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2230.2003.01308.x","article-title":"Prediction of outcome in the treatment of onychomycosis","volume":"28","author":"Sommer","year":"2003","journal-title":"Clinical and Experimental Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2133.1997.6661651.x","article-title":"Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group","volume":"136","author":"Tausch","year":"1997","journal-title":"British Journal of Dermatology"},{"issue":"Suppl 39","key":"10.1002\/14651858.CD010031.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb00008.x","article-title":"A randomized treatment duration-finding study of terbinafine in onychomycosis","volume":"126","author":"Schroeff","year":"1992","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0091|cit91","unstructured":"Warshaw EM Carver SM Zielke GR Ahmed DD Intermittent terbinafine for toenail onychomycosis: is it effective? Results of a randomized pilot trial Archives of Dermatology 2001 1253"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaad.2005.04.055","article-title":"Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial","volume":"53","author":"Warshaw","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3314\/jjmm.45.143","article-title":"Optimal dosages and cycles of itraconazole pulse therapy for onychomycosis","volume":"45","author":"Watanabe","year":"2004","journal-title":"Japanese Journal of Medical Mycology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0378-6323.158634","article-title":"Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial","volume":"81","author":"Yadav","year":"2015","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"issue":"6","key":"10.1002\/14651858.CD010031.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0190-9622(83)70208-2","article-title":"A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize","volume":"9","author":"Zaias","year":"1983","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004766","article-title":"Oral treatments for toenail onychomycosis","author":"Bell-Syer","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD010031.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/myc.12504","article-title":"Non-dermatophytic onychomycosis diagnostic criteria: an unresolved question","volume":"59","author":"Bombace","year":"2016","journal-title":"Mycoses"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/JCM.02072-06","article-title":"Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum","volume":"45","author":"Brillowska-Dabrowska","year":"2007","journal-title":"Journal of Clinical Microbiology"},{"issue":"10","key":"10.1002\/14651858.CD010031.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1468-3083.2009.03225.x","article-title":"Onychomycosis and diabetes","volume":"23","author":"Cathcart","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001434.pub2","article-title":"Topical treatments for fungal infections of the skin and nails of the foot","author":"Crawford","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"20","key":"10.1002\/14651858.CD010031.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMcp0804878","article-title":"Clinical practice. Fungal nail disease","volume":"360","author":"Berker","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clindermatol.2013.06.006","article-title":"Nail anatomy","volume":"31","author":"Berker","year":"2013","journal-title":"Clinics in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40257-013-0056-2","article-title":"Oral therapy for onychomycosis: an evidence-based review","volume":"15","author":"Sa","year":"2014","journal-title":"American Journal of Clinical Dermatology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010031.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0190-9622(98)70199-9","article-title":"Effect of onychomycosis on quality of life","volume":"38","author":"Drake","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD010031.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","article-title":"The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life","volume":"41","author":"Drake","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD010031.pub2-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009992.pub2","article-title":"Topical antifungal treatments for tinea cruris and tinea corporis","author":"El-Gohary","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD010031.pub2-BIB0107|cit107","first-page":"38","article-title":"Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical Therapy","volume":"8","author":"Elewski","year":"2015","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0108|cit108","volume-title":"Therapeutic Guidelines: Dermatology. Version 3","author":"Dermatology Expert Group","year":"2009"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0109|cit109","unstructured":"Ferrari J Fungal toenail infections BMJ Clinical Evidence 2011 1715"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0110|cit110","first-page":"257","article-title":"Surgical anatomy of the nail unit","volume":"27","author":"Fleckman","year":"2001","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaad.2003.07.011","article-title":"Modulation of linear nail growth to treat diseases of the nail","volume":"50","author":"Geyer","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD010031.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"e1004105","DOI":"10.1371\/journal.ppat.1004105","article-title":"Fungal nail infections (onychomycosis): a never-ending story?","volume":"10","author":"Ghannoum","year":"2014","journal-title":"PLoS Pathogens"},{"issue":"12","key":"10.1002\/14651858.CD010031.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/jcph.400","article-title":"Liver injury associated with ketoconazole: review of the published evidence","volume":"54","author":"Greenblatt","year":"2014","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD010031.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1439-0507.2012.02199.x","article-title":"An update on treatment of onychomycosis","volume":"55","author":"Grover","year":"2012","journal-title":"Mycoses"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD010031.pub2-BIB0116|cit116","first-page":"677-98; quiz 69","article-title":"Antifungal agents: an overview. Part I","volume":"30","author":"Gupta","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD010031.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"911-33; quiz 93","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents: an overview. Part II","volume":"30","author":"Gupta","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey","volume":"139","author":"Gupta","year":"1998","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clindermatol.2013.06.009","article-title":"Diagnosing onychomycosis","volume":"31","author":"Gupta","year":"2013","journal-title":"Clinics in dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7547\/13-110.1","article-title":"Therapies for Onychomycosis A Systematic Review and Network Meta-analysis of Mycological Cure","volume":"105","author":"Gupta","year":"2015","journal-title":"Journal of the American Podiatric Medical Association"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Hay RJ Baran R Onychomycosis: a proposed revision of the clinical classification Journal of the American Academy of Dermatology 2011 1219 27","DOI":"10.1016\/j.jaad.2010.09.730"},{"issue":"7417","key":"10.1002\/14651858.CD010031.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0123|cit123","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7626","key":"10.1002\/14651858.CD010031.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.12178","article-title":"Risk of oral antifungal agent-induced liver injury in Taiwanese","volume":"77","author":"Kao","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00128071-200910040-00001","article-title":"Toenail onychomycosis in diabetic patients: issues and management","volume":"10","author":"Mayser","year":"2009","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0127|cit127","unstructured":"Poulakos M Grace Y Machin JD Dorval E Efinaconazole and tavaborole: emerging antifungal alternatives for the topical treatment of onychomycosis Journal of Pharmacy Practice 10.1177\/0897190016630904"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0128|cit128","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD010031.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0130|cit130","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A The GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendations www.guidelinedevelopment.org\/handbook 2013"},{"issue":"1","key":"10.1002\/14651858.CD010031.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00019053-200220010-00003","article-title":"Onychomycosis: health-related quality of life considerations","volume":"20","author":"Shaw","year":"2002","journal-title":"PharmacoEconomics"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0378-6323.39584","article-title":"Comparison of potassium hydroxide mount and mycological culture with histopathologic examination using periodic acid-Schiff staining of the nail clippings in the diagnosis of onychomycosis","volume":"74","author":"Shenoy","year":"2008","journal-title":"Indian journal of dermatology, venereology and leprology"},{"issue":"3","key":"10.1002\/14651858.CD010031.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JCM.05164-11","article-title":"Identification of infectious agents in onychomycoses by Polymerase Chain Reaction-Terminal Restriction Fragment Length Polymorphism","volume":"50","author":"Verrier","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD010031.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.2009.00741.x","article-title":"Epidemiological survey of foot diseases in Japan: results of 30,000 foot checks by dermatologists","volume":"37","author":"Watanabe","year":"2010","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010031.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1067\/S0190-9622(03)01480-4","article-title":"Comparison of diagnostic methods in the evaluation of onychomycosis","volume":"49","author":"Weinberg","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010031.pub2-BIB0136|cit136","volume-title":"Fitzpatrick's Dermatology in General Medicine","author":"Wolff","year":"2007"},{"issue":"4","key":"10.1002\/14651858.CD010031.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11096-014-9969-y","article-title":"Systematic review of severe acute liver injury caused by terbinafine","volume":"36","author":"Yan","year":"2014","journal-title":"International Journal of Clinical Pharmacy"},{"issue":"8","key":"10.1002\/14651858.CD010031.pub2-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010031","article-title":"Oral antifungal medication for toenail onychomycosis","author":"Kreijkamp-Kaspers","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010031.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:01:19Z","timestamp":1719324079000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010031.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":138,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010031.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}